Medical Devices Series B Investors & VC Firms

660 firms in this list, with a median first check of $730K. 140 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
AM Amzak Health JETNDSMC5 people	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
TR Treo Ventures, Llc BHMJTPDS5 people	88🔒	Minneapolis	US	Seed–Late Stage	—	+ Add to CRM
VI VIVES Partners AVPDSSYV4 people	88🔒	Wavre	BE	Pre-Seed–Series B	$108K – $7.6M	+ Add to CRM
AM Ambit Health Ventures NFMRSGZP4 people · Leads rounds	88🔒	Boston	US	Seed–Series B	—	+ Add to CRM
BL BlueStone Venture Partners MATNCBAM4 people	88🔒	Tucson	US	Seed–Series B	$250K – $1M	+ Add to CRM
AD AddVentures by SCG SPCLPJRM6 people	88🔒	Bangkok	TH	Seed–Late Stage	$1.5M – $66M	+ Add to CRM
BA Ballad Ventures MABWB3 people	88🔒	Johnson City	US	Pre-Seed–Series B	$500K – $1.5M	+ Add to CRM
FU Funds Startups Leads rounds	88🔒	Tokyo	JP	Seed–Late Stage	$66M	+ Add to CRM
MA Mammoth Research EHJYKMMM9 people	88🔒	Fort Wayne	US	Series A–Growth	—	+ Add to CRM
AR Artiman Ventures ASASBWRR10 people	88🔒	Palo Alto	US	Seed–Late Stage	$2M – $6M	+ Add to CRM
AR Archetype Ventures HKJNKMSF6 people	88🔒	Tokyo	JP	Pre-Seed–Growth	$875K – $92M	+ Add to CRM
IN InVivium Capital CCMLALAP6 people	88🔒	Chicago	US	Seed–Late Stage	—	+ Add to CRM
PA Partners Investment Co. Ltd. CLJAJSSS9 people · Follows rounds	88🔒	Seoul	KR	Series A–Late Stage	—	+ Add to CRM
VE Venture Management TFMTDM3 people	88🔒	Madison	US	Seed–Growth	—	+ Add to CRM
EC Ecliptic Capital ALMWWHJP5 people · Leads rounds	88🔒	Austin	US	Pre-Seed–Series B	$50K – $5M	+ Add to CRM
SM Smilegate Investment BAHCHNIP11 people	88🔒	Seoul	KR	Seed–Growth	$694K – $35M	+ Add to CRM
TR Truffle Capital BRHMJNNN5 people · Leads rounds	88🔒	Paris	FR	Seed–Growth	$5M – $15M	+ Add to CRM
TR TransPacific Venture Partners MLPJ2 people	88🔒	Taipei City	TW	Seed–Series B	$500K – $3M	+ Add to CRM
WH Whiz Partners Inc. 安俊藤朋HFTS6 people	88🔒	Tokyo	JP	Seed–Late Stage	$500K – $5M	+ Add to CRM
TA Tauros Capital BPCNMW3 people	88🔒	Vienna	AT	Series A–Growth	$2.2M	+ Add to CRM
AM AmorChem KMIHPLLT5 people	88🔒	Montreal	CA	Pre-Seed–Series B	—	+ Add to CRM
ED EDB Investments CKCLCGJO11 people	88🔒	Singapore	SG	Seed–Late Stage	$12M – $400M	+ Add to CRM
JO Joy Capital ELKLMDAL5 people	88🔒	Beijing	CN	Seed–Growth	—	+ Add to CRM
SO Southern Cross Venture Partners BCJWDMJS5 people	88🔒	Narrabeen	AU	Seed–Late Stage	$1.3M – $6.6M	+ Add to CRM

Amzak Health

New YorkSeed–Late Stage

JETNDSMC5 people

Treo Ventures, Llc

MinneapolisSeed–Late Stage

BHMJTPDS5 people

VIVES Partners

WavrePre-Seed–Series B$108K – $7.6M

AVPDSSYV4 people

Ambit Health Ventures

BostonSeed–Series B

NFMRSGZP4 people

BlueStone Venture Partners

TucsonSeed–Series B$250K – $1M

MATNCBAM4 people

AddVentures by SCG

BangkokSeed–Late Stage$1.5M – $66M

SPCLPJRM6 people

Ballad Ventures

Johnson CityPre-Seed–Series B$500K – $1.5M

MABWB3 people

Funds Startups

TokyoSeed–Late Stage$66M

Mammoth Research

Fort WayneSeries A–Growth

EHJYKMMM9 people

Artiman Ventures

Palo AltoSeed–Late Stage$2M – $6M

ASASBWRR10 people

Archetype Ventures

TokyoPre-Seed–Growth$875K – $92M

HKJNKMSF6 people

InVivium Capital

ChicagoSeed–Late Stage

CCMLALAP6 people

Partners Investment Co. Ltd.

SeoulSeries A–Late Stage

CLJAJSSS9 people

Venture Management

MadisonSeed–Growth

TFMTDM3 people

Ecliptic Capital

AustinPre-Seed–Series B$50K – $5M

ALMWWHJP5 people

Smilegate Investment

SeoulSeed–Growth$694K – $35M

BAHCHNIP11 people

Truffle Capital

ParisSeed–Growth$5M – $15M

BRHMJNNN5 people

TransPacific Venture Partners

Taipei CitySeed–Series B$500K – $3M

MLPJ2 people

Whiz Partners Inc.

TokyoSeed–Late Stage$500K – $5M

安俊藤朋HFTS6 people

Tauros Capital

ViennaSeries A–Growth$2.2M

BPCNMW3 people

AmorChem

MontrealPre-Seed–Series B

KMIHPLLT5 people

EDB Investments

SingaporeSeed–Late Stage$12M – $400M

CKCLCGJO11 people

Joy Capital

BeijingSeed–Growth

ELKLMDAL5 people

Southern Cross Venture Partners

NarrabeenSeed–Late Stage$1.3M – $6.6M

BCJWDMJS5 people

Data sourced from public filings and firms' own websites — see our methodology.